SLC6A4 (aa605-618) Antibody from MYBIOSOURCE INC.
Search, find, compare suppliers for anti-SLC6A4 (aa605-618) antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | SLC6A4 (aa605-618) |
| Clone | polyclonal |
| Host Species | Goat |
| Reactive Species | mouse; expected from sequence similarity: human, mouse, rat, cow |
| Isotype | n/a |
| Format | antigen affinity purified |
| Size | 0.1 mg |
| Concentration | 100ug specific antibody in 200ul |
| Applications | Peptide ELISA (EIA), Western Blot (WB) |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | n/a |
| Immunogen | Immunogen: Peptide with sequence C-KERIIKSITPETPT, from the C Terminus of the protein sequence according to NP_001036.1. Epitope: C Terminus |
| Other Names | [Goat SLC6A4 / 5HTT / SERT; SLC6A4; solute carrier family 6 (neurotransmitter transporter, serotonin), member 4; 5-HTT; 5-HTTLPR; 5HTT; HTT; OCD1; SERT; hSERT; 5-hydroxytryptamine transporter; 5HT transporter; Na+/Cl- dependent serotonin transporter; OTTHUMP00000163632; OTTHUMP00000; 5HT transporter; 5HTT; 5-HTT; 5-HTTLPR; 5-hydroxytryptamine transporter; hSERT; HTT; Na+/Cl- dependent serotonin transporter; OCD1; OTTHUMP00000163632; OTTHUMP00000163633; SERT; sodium-dependent serotonin transporter; solute carrier family 6 (neurotransmitter transporter; serotonin); member 4; solute carrier family 6 member 4; SLC6A4; SLC6A4 (aa605-618)], [SLC6A4; SLC6A4; HTT; 5HTT; OCD1; SERT; 5-HTT; SERT1; hSERT; 5-HTTLPR; HTT; SERT; 5HTT] |
| Gene, Accession # | [SLC6A4], Gene ID: 6532, NCBI: NP_001036.1 |
| Catalog # | MBS422851 |
| Price | $305 |
| Order / More Info | SLC6A4 (aa605-618) Antibody from MYBIOSOURCE INC. |
| Product Specific References | n/a |
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166
sales@mybiosource.com
http://www.MyBioSource.com
Profile of MYBIOSOURCE INC.
Return to Antibodies